Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

OBJECTIVE: We performed a review of studies of fluticasone propionate (FP)/salmeterol (SAL) (combination inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA)) in patients with COPD, which measured baseline (pretreatment) blood eosinophil levels, to test whether blood eosinophil levels ≥2% were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorax
Autors principals: Pavord, Ian D, Lettis, Sally, Locantore, Nicholas, Pascoe, Steve, Jones, Paul W, Wedzicha, Jadwiga A, Barnes, Neil C
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Chronic Obstructive Pulmonary Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4752631/
https://ncbi.nlm.nih.gov/pubmed/26585525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2015-207021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars